Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H7NO3 |
Molecular Weight | 129.114 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)OC(=O)NC1=O
InChI
InChIKey=JYJFNDQBESEHJQ-UHFFFAOYSA-N
InChI=1S/C5H7NO3/c1-5(2)3(7)6-4(8)9-5/h1-2H3,(H,6,7,8)
Molecular Formula | C5H7NO3 |
Molecular Weight | 129.114 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dimethadione (5,5-dimethyl-2,4-oxazolidinedione) is the N-demethylated metabolite of the anticonvulsant trimethadione. Dimethadione is considered to be a blocker of T-type calcium channel. Dimethadione also inhibits a specific potassium channel (Ikr) in HERG-transfected cells. It exerts teratogenic effect especially congenital heart defects. Dimethadione can be used for the measurement of regional tissue pH using positron emission tomography.
CNS Activity
Originator
Sources: http://pubs.acs.org/doi/10.1021/ja01854a019
Curator's Comment: reference retrieved from www.drugfuture.com/chemdata/dimethadione.html
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL240 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12027905 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Trimethadione N-demethylation by rat liver CYP2E1 in vitro. | 1996 Jul |
|
Na(+)-dependent pH regulation by the amitochondriate protozoan parasite Giardia intestinalis. | 2001 Aug 3 |
|
The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia. | 2001 Dec |
|
Altering intracellular pH disrupts development and cellular organization in preimplantation hamster embryos. | 2001 Jun |
|
Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. | 2002 Mar-Apr |
|
Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? | 2002 May |
|
Disruption of bovine oocytes and preimplantation embryos by urea and acidic pH. | 2003 Apr |
|
Discriminative power of an assay for automated in vitro screening of teratogens. | 2004 Aug |
|
Thoracic skeletal defects and cardiac malformations: a common epigenetic link? | 2006 Dec |
|
Interactive effects of cadmium and all-trans-retinoic acid on the induction of forelimb ectrodactyly in C57BL/6 mice. | 2006 Jan |
|
Pharmacological evidence that stalk cell differentiation involves increases in the intracellular Ca(2+) and H(+) concentrations in Dictyostelium discoideum. | 2007 Apr |
|
Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity. | 2007 Aug |
|
Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs. | 2007 Jul |
|
Glucose loading precipitates focal lactic acidosis in the vulnerable medial thalamus of thiamine-deficient rats. | 2008 Mar |
|
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. | 2009 |
|
Acidic and basic solutions dissolve protein plugs made of lithostathine complicating choledochal cyst/pancreaticobiliary maljunction. | 2009 Jul |
|
Alterations in mouse embryo intracellular pH by DMO during culture impair implantation and fetal growth. | 2010 Aug |
|
In utero dimethadione exposure causes postnatal disruption in cardiac structure and function in the rat. | 2014 Dec |
|
Maternal rat serum concentrations of dimethadione do not explain intra-litter differences in the incidence of dimethadione-induced birth defects, including novel findings in foetal lung. | 2014 Dec 4 |
|
In Utero Exposure to a Cardiac Teratogen Causes Reversible Deficits in Postnatal Cardiovascular Function, But Altered Adaptation to the Burden of Pregnancy. | 2015 Nov |
Sample Use Guides
To generate rats with resolved congenital heart defects, pregnant rats were administered distilled water or dimethadione [300 mg/kg b.i.d. on gestation day (gd) 9 and 10] and pups delivered naturally.
In order to detect both pancreatic excretion of dimethadione (DMO), a weak organic acid, and the effect of pancreatic DMO on secretin-stimulated pancreatic secretion, DMO was given intravenously to dogs with pancreatic fistulae at a dose of 50, 100 and 200 mg/kg.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8925801
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:51 GMT 2023
by
admin
on
Fri Dec 15 15:13:51 GMT 2023
|
Record UNII |
ALU9NPM703
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
695-53-4
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
100000082641
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY | |||
|
SUB07170MIG
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
DTXSID2020478
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL1099
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
C171703
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY | |||
|
3081
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY | |||
|
211-781-4
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
D004114
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY | |||
|
1130
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
m4505
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY | Merck Index | ||
|
ALU9NPM703
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
30152
Created by
admin on Fri Dec 15 15:13:52 GMT 2023 , Edited by admin on Fri Dec 15 15:13:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
Dimethadione has anticonvulsant activity and has been used clinically in the treatment of petit mal epilepsy.
|
||
|
PARENT -> METABOLITE TOXIC |
Renal tubular and hepatic necrosis in man.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |